Dan Sheng
Director/Board Member at BEIJING STRONG BIOTECHNOLOGIES,INC.
Net worth: 907 594 $ as of 29/04/2024
Profile
Dan Sheng has held multiple positions throughout her career.
Currently, she is the Director & Executive Deputy General Manager at Beijing Strong Biotechnologies, Inc. since 2016.
She is also a Member-Supervisory Board at Fuzhou Maixin Biotech Co., Ltd.
since 2020.
In terms of education, Dr. Sheng holds an MBA from The University of Chicago, which she obtained in 2012.
She also has a doctorate degree from New York University, conferred in 2004.
Additionally, she completed her undergraduate studies at the University of Science & Technology of China in 2000.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 07/05/2023 | 354,687 ( 0.11% ) | 907 594 $ | 29/04/2024 |
Dan Sheng active positions
| Companies | Position | Start |
|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Director/Board Member | 12/08/2020 |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Director/Board Member | 29/09/2020 |
Training of Dan Sheng
| University of Science & Technology of China | Undergraduate Degree |
| New York University | Doctorate Degree |
| The University of Chicago | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Private companies | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
- Stock Market
- Insiders
- Dan Sheng
